Systemic FIV vector administration: Transduction of CNS immune cells and Purkinje neurons

Stephanos Kyrkanides, Jennie H. Miller, Howard J. Federoff

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


The systemic effects of gene therapy have been previously described in a variety of peripheral organs following intravenous administration or intraperitoneal inoculation of viral vectors, as well as in the brain following intracranial administration. However, limited information is available on the ability of viral vectors to cross the blood-brain barrier and infect cells located within the central nervous system (CNS). We employed a VSV-G pseudotyped FIV(lacZ) vector capable of transducing dividing, growth-arrested, as well as post-mitotic cells with the reporter gene lacZ. Adult mice were injected intraperitoneally with FIV(lacZ), and the expression of β-galactosidase was studied 5 weeks following treatment in the brain, liver, spleen and kidney by X-gal histochemistry and immunocytochemistry. Interestingly, relatively low doses of FIV(lacZ) administered intraperitoneally lead to β-galactosidase detection in the brain and cerebellum. The identity of these cells was confirmed by double immunofluorescence, and included CD31-, CD3- and CD11b-positive cells. Fluorescent microspheres co-injected with FIV(lacZ) virus were identified within mononuclear cells in the brain parenchyma, suggesting infiltration of peripheral immune cells in the CNS. Cerebellar Purkinje neurons were also transduced in all adult-injected mice. Our observations indicate that relatively low doses of FIV(lacZ) administered intraperitoneally resulted in the transduction of immune cells in the brain, as well as a specific subset of cerebellar neurons.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalMolecular Brain Research
Issue number1
StatePublished - Nov 6 2003

Bibliographical note

Funding Information:
We would like to thank Dr. William H. Bowen and Dr. David L. Felten for their critical review of the manuscript. This study was supported in part by NIH grants DE13860, DE00471 and DE14700.


  • Beta-galactosidase
  • Brain
  • Cerebellum
  • Feline
  • Gene therapy
  • Immunodeficiency virus
  • Injections
  • Intraperitoneal
  • Mouse

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Systemic FIV vector administration: Transduction of CNS immune cells and Purkinje neurons'. Together they form a unique fingerprint.

Cite this